Mexico's Diario Oficial of Nov. 21, lists notices from the Secretary of the Economy as follows:
The Nuclear Regulatory Commission is asking for comments by Feb. 6 on its draft plan for retrospective review of its existing regulations. The draft plan, which is available here, includes discussions of: (1) efforts to incorporate risk assessments into regulatory decision-making; (2) efforts to address the cumulative effects of regulation; (3) the NRC’s methodology for prioritizing its rulemaking activities; (4) rulemaking initiatives arising out of the NRC’s ongoing review of its regulations related to the recent events at the Fukushima Dai-ichi Nuclear Power Plant in Japan; and (5) the NRC’s previous and ongoing efforts to update its regulations in a systematic, ongoing basis. This request for comment is solely for information and program-planning purposes, NRC said.
The International Trade Administration published notices in the Nov. 21 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
On Nov. 20 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration warned Chinese and Japanese device manufacturers that their products do not conform to current good manufacturing practice (CGMP) requirements of the Quality System regulation, in two warning letters dated Nov. 13. Premarket approval applications for related devices, and Requests for Certificates to Foreign Governments, will not be approved until Chinese company A&D Electronics (Shenzhen) (here) and Japanese company Osachi (here) correct the violations, FDA said. In its warning letter to Osachi, FDA also said the company’s devices are misbranded because it has no written Medical Device Reporting procedures.
The Food and Drug Administration said in two warning letters that it may place devices manufactured by United Kingdom-based Integra Neurosciences (here) and Denmark-based Tonica Elektronik (here) on import alert after inspections revealed deviations from current good manufacturing requirements at both companies’ facilities. Integra also offered for sale a non-FDA approved device in a catalog distributed in the U.S., FDA said in its warning letter to the company. Both facilities will be subject to reinspection to ensure compliance, FDA said.
On Nov. 20 the Foreign Agricultural Service issued the following GAIN reports:
The Animal and Plant Health Inspection Service announced changes Nov. 20 to Plant Protection and Quarantine (PPQ) electronic manuals. While some changes are minor, other changes may affect the admissibility of the plant products, including fruits, vegetables, and flowers.
The Foreign Trade Zones Board issued the following notices for Nov. 21:
The Bureau of Industry and Security announced a partially open meeting of the Emerging Technology and Research Advisory Committee (ETRAC) Dec. 12-13. At the open session Dec. 13 at 8:30 a.m. ET, the ETRAC will hear an overview on export controls for new members, and discuss the 521 ECCNs (not elsewhere listed on the Commerce Control List), 3D bio-printing, a National Academy of the Sciences nanotech initiative, a rare earths study, and additive manufacturing. The open session will be accessible via teleconference to 40 participants on a first come, first served basis. To participate, submit inquiries to Yvette Springer at Yvette.Springer@bis.doc.gov, no later than Dec. 5.